--KeyBanc Capital Markets Trims Price Target on Harvard Bioscience to $7 From $10, Keeps Overweight Rating
12:09PM ET 8/05/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...